CRINETICS PHARMACEUTICALS, INC. (CRNX) SEC News March 12, 2026, 20:28 UTC 1 1 comments 📋 ROGERIO VIVALDI COELHO (Director) plans to sell 5K shares of Crinetics Pharmaceuticals, Inc. (at $36.98 each, total $185K) Filed: Mar 12, 2026 | ID: 002543 Comment Full text
PRECIGEN, INC. (PGEN) SEC News March 12, 2026, 20:27 UTC 1 1 comments Director KINDLER JEFFREY B 🟢 acquired 96.3K shares (2 derivative) of PRECIGEN, INC. (PGEN) at $3.51 Transaction Date: Mar 10, 2026 | Filing ID: 003688 Comment Full text
SAREPTA THERAPEUTICS, INC. (SRPT) SEC News March 12, 2026, 20:27 UTC 1 1 comments 📋 STEPHEN MAYO (Director) plans to sell 7K shares of SAREPTA THERAPEUTICS, INC. (at $17.02 each, total $123K) Filed: Mar 12, 2026 | ID: 002538 Comment Full text
PRECIGEN, INC. (PGEN) SEC News March 12, 2026, 20:26 UTC 1 1 comments Director Hassan Fred 🟢 acquired 94.6K shares (2 derivative) of PRECIGEN, INC. (PGEN) at $3.51 Transaction Date: Mar 10, 2026 | Filing ID: 003687 Comment Full text
NEWAMSTERDAM PHARMA CO N.V. (NAMS) SEC News March 12, 2026, 20:25 UTC 1 1 comments LANGE LOUIS G 🔴 sold 44.6K shares of NewAmsterdam Pharma Co N.V. (NAMS) at $31.23 ($1.4M) Transaction Date: Mar 11, 2026 | Filing ID: 104239 Comment Full text
PRECIGEN, INC. (PGEN) SEC News March 12, 2026, 20:25 UTC 3 1 comments Director Gupta Vinita D 🟢 acquired 94.6K shares (2 derivative) of PRECIGEN, INC. (PGEN) at $3.51 Transaction Date: Mar 10, 2026 | Filing ID: 003685 Comment Full text
BRISTOL-MYERS SQUIBB CO. (BMYMP) SEC News March 12, 2026, 20:24 UTC 3 1 comments Hickey Benjamin 🟢 acquired 28.6K shares (2 derivative) of BRISTOL MYERS SQUIBB CO (BMY) Transaction Date: Mar 10, 2026 | Filing ID: 000006 Comment Full text
BRISTOL-MYERS SQUIBB CO. (BMYMP) SEC News March 12, 2026, 20:23 UTC 3 1 comments Shibutani Hiroshi Chris 🟢 acquired 19.6K shares (2 derivative) of BRISTOL MYERS SQUIBB CO (BMY) Transaction Date: Mar 10, 2026 | Filing ID: 000002 Comment Full text
CENTURY THERAPEUTICS, INC. (IPSC) SEC News March 12, 2026, 20:23 UTC 3 1 comments 📋 Russotti Gregory (Officer) plans to sell 10K shares of Century Therapeutics, Inc. (at $2.55 each, total $26K) Filed: Mar 12, 2026 | ID: 002261 Comment Full text
PRECIGEN, INC. (PGEN) SEC News March 12, 2026, 20:23 UTC 3 1 comments Director Frank Steven 🟢 acquired 90.9K shares (2 derivative) of PRECIGEN, INC. (PGEN) at $3.51 Transaction Date: Mar 10, 2026 | Filing ID: 003684 Comment Full text